| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/29/1998 | EP0837691A1 Vaccination with peptide of mhc class ii molecules for treatment of autoimmune disease |
| 04/29/1998 | EP0837672A1 Preparations and methods for the treatment of t cell mediated diseases |
| 04/29/1998 | EP0837629A1 Pericardial therapeutic and diagnostic agent delivery |
| 04/29/1998 | EP0644200B1 Cell surface protein from brevibacterium lactofermentum |
| 04/29/1998 | EP0465529B1 Expression of exogenous polynucleotide sequences in a vertebrate |
| 04/29/1998 | CN1180379A Methods and compositions for secretion of heterologous polypeptides |
| 04/29/1998 | CN1180312A Anti-obesity proteins |
| 04/29/1998 | CN1180106A Glucokinase gene and its high expression engineering strain |
| 04/29/1998 | CA2214866A1 Novel spo-rel |
| 04/28/1998 | US5744693 Plants having altered floral development |
| 04/28/1998 | US5744692 Nucleotide sequences coding an endopolygalacturonase inhibitor |
| 04/28/1998 | US5744594 DNA encoding ATP-sensitive potassium channel genes |
| 04/28/1998 | US5744593 Parasitic helminth larval thiol specific antioxidant proteins and nucleic acid molecules |
| 04/28/1998 | US5744587 Method for purifying thrombopoietin |
| 04/28/1998 | US5744586 Manufacturing process for the production of purified transferrin |
| 04/28/1998 | US5744584 Antithrombosis agents |
| 04/28/1998 | US5744580 Fusion protein |
| 04/28/1998 | US5744579 Recombinant DNA vectors capable of expressing apoaequorin |
| 04/28/1998 | US5744545 Biocompatible adhesive compositions |
| 04/28/1998 | US5744496 Method of treating cardiac insufficiency using angiotensin-converting enzyme inhibitors |
| 04/28/1998 | US5744456 Vector contining promoter and gene |
| 04/28/1998 | US5744451 N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity |
| 04/28/1998 | US5744449 Lethal toxin neutralizing factors |
| 04/28/1998 | US5744448 Human follicle stimulating hormone receptor |
| 04/28/1998 | US5744446 Hybrid human/animal factor VIII |
| 04/28/1998 | US5744445 Cystic fibrosis, neoplasias, bronchogenic cancers, pneumonia, broncopulmonary microbial infections; delivered by mouth or aerosol to respiratory or gastrointestinal systems |
| 04/28/1998 | US5744444 HPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereof |
| 04/28/1998 | US5744442 Regulation of cellular invasiveness |
| 04/28/1998 | US5744368 Contacting a sample containing transthyretin with amyloid to form a complex and detecting said complex |
| 04/28/1998 | US5744364 PTOM36 constructs and tomato cells transformed therewith |
| 04/28/1998 | US5744354 Peptides for isolating and inhibiting calcineurin |
| 04/28/1998 | US5744353 Cytolytic T cell lines which bind to complexes of tumor rejection antigens and HLA-B44 molecules |
| 04/28/1998 | US5744348 Genetic engineering |
| 04/28/1998 | US5744346 Capable of cleaving 695-amino acid isotype of beta-amyloid precursor protein between amino acids 596 and 597 |
| 04/28/1998 | US5744340 Expression of human inducible nitric oxide synthase |
| 04/28/1998 | US5744334 Transformation with promoter-gene construct |
| 04/28/1998 | US5744329 DNA encoding fused di-beta globins and production of pseudotetrameric hemoglobin |
| 04/28/1998 | US5744328 Production of proteins in procaryotes |
| 04/28/1998 | US5744327 Methods for producing insulin in response to non-glucose secretagogues |
| 04/28/1998 | US5744326 Vector comprising an intronless gene and one or more copies of the regulatory element |
| 04/28/1998 | US5744324 Useful in drug screening assays directed to modulation of cellular electrophysiology |
| 04/28/1998 | US5744323 Process for producing heme proteins |
| 04/28/1998 | US5744316 Used to identify individuals diagnosed with conditions characterized by cellular abnormalities |
| 04/28/1998 | US5744315 Compounds from biopolymers and effector substances which are linked via optically active amino acid derivatives, processes for the preparation thereof and the use thereof |
| 04/28/1998 | US5744314 Periplasmic membrane-bound system for detecting protein-protein interactions |
| 04/28/1998 | US5744313 Assay employing novel protein domain which binds tyrosine phosphorylated proteins |
| 04/28/1998 | US5744310 Bax promoter sequence and screening assays for indentifying agents that regulate bax gene expression |
| 04/28/1998 | US5744306 Methods for nucleic acid detection, sequencing, and cloning using exonuclease |
| 04/28/1998 | US5744304 Introducing into cell vector including selected protein gene under control of heterologous inflammation responsive promoter, contacting with cytokine which activates gene to express protein |
| 04/28/1998 | US5744301 Methods of detection of epstein barr virus induced genes expressed in the placenta |
| 04/28/1998 | US5744298 DNA sequences which encode immunoreactive HCMV-specific peptides |
| 04/28/1998 | US5744144 Synthetic multiple tandem repeat mucin and mucin-like peptides, and uses thereof |
| 04/28/1998 | US5744143 Viral vaccines |
| 04/28/1998 | US5744142 Self-assembling recombinant papillomavirus capsid proteins |
| 04/28/1998 | US5744141 Flavivirus recombinant poxvirus immunological composition |
| 04/28/1998 | US5744140 Recombinant poxvirus containing forein dna from encephalitis virus protein m or virus protein e, ns1, and ns2a |
| 04/28/1998 | US5744133 Expression of a tumor-specific antigen by a recombinant vector virus and use thereof in preventitive or curative treatment of the corresponding tumor |
| 04/28/1998 | US5744131 Sequence-directed DNA-binding molecules compositions and methods |
| 04/28/1998 | US5744120 Phosphine or arsine ligated technetium-99m labeled hydrazino or diazino modified biologically active molecules that selectively localize at sites of disease |
| 04/28/1998 | US5744002 Paper strengthened with solubilized collagen and method |
| 04/28/1998 | US5743477 Lipid acyl hydrolase |
| 04/28/1998 | CA2216039A1 Plug for an optical plug connector |
| 04/28/1998 | CA2102859C Expression vector for phytolacca antiviral protein |
| 04/28/1998 | CA2057926C Chemical products |
| 04/28/1998 | CA2030108C Process for the preparation of genetic vectors for the expression of nerve growth factor in eukaryotic cells |
| 04/28/1998 | CA1339842C Methods of generating desired amino-terminal residues in proteins |
| 04/23/1998 | WO1998016825A1 METHOD FOR ASSAYING AGALACTO-IgG AND ASSAY KITS, POLYPEPTIDES OF LECTINS, AND DNAS ENCODING THE SAME |
| 04/23/1998 | WO1998016658A2 Probes, methods and kits for detection and typing of helicobacter pylori nucleic acids in biological samples |
| 04/23/1998 | WO1998016657A1 Protease regulator screening assay |
| 04/23/1998 | WO1998016654A1 Production of a multimeric protein by cell fusion method |
| 04/23/1998 | WO1998016647A1 Hepatitis c virus epitope |
| 04/23/1998 | WO1998016646A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 04/23/1998 | WO1998016645A2 Compounds and methods for diagnosis of tuberculosis |
| 04/23/1998 | WO1998016644A1 Fibroblast growth factor homologs |
| 04/23/1998 | WO1998016643A1 Brain-associated inhibitor of tissue-type plasminogen activator |
| 04/23/1998 | WO1998016642A1 Keratinocyte growth factor-2 products |
| 04/23/1998 | WO1998016641A1 Isolation and method of using tissue growth-inducing frzb protein |
| 04/23/1998 | WO1998016640A1 Human reg i-gamma protein |
| 04/23/1998 | WO1998016639A1 Rdgb-proteins |
| 04/23/1998 | WO1998016638A1 Consolidated ligands with increased affinities and methods of use thereof |
| 04/23/1998 | WO1998016637A1 Fanconi gene 1 |
| 04/23/1998 | WO1998016635A1 Insulin homologs |
| 04/23/1998 | WO1998016634A1 Transgene expression |
| 04/23/1998 | WO1998016627A1 Transgenic non-human mammal expressing flag-app-c100 fusion protein |
| 04/23/1998 | WO1998016557A1 Assays for g-protein-linked receptors |
| 04/23/1998 | WO1998016556A1 Pharmaceutical and diagnostic use of serum amyloid p component |
| 04/23/1998 | WO1998016555A1 Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide |
| 04/23/1998 | WO1998016554A1 Nucleic acid vaccines against rickettsial diseases and methods of use |
| 04/23/1998 | WO1998016553A1 Bordetella strain expressing the fha hybrid, liposomes and vaccines |
| 04/23/1998 | WO1998016552A1 Helicobacter pylori live vaccine |
| 04/23/1998 | WO1998016551A2 Variants of vascular endothelial cell growth factor having antagonistic properties |
| 04/23/1998 | WO1998016550A1 Chiral peptide nucleic acids |
| 04/23/1998 | WO1998016548A1 Thrombin receptor peptides and uses thereof |
| 04/23/1998 | WO1998016545A1 Therapeutic proteins |
| 04/23/1998 | WO1998016542A1 NOVEL PENICILLIN BINDING PROTEIN FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 04/23/1998 | WO1998016541A1 Magnetically activated cell sorting for production of proteins |
| 04/23/1998 | WO1998016255A2 Stabilized conjugates of uncomplexed subunits of multimeric proteins |
| 04/23/1998 | WO1998016254A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/23/1998 | WO1998016245A1 Method of autoantibody assay |
| 04/23/1998 | WO1998016241A1 Method of disrupting cellular adhesion |